Michael Goettler resigns from Bausch Health board to lead Knoa Pharma

Bausch Health's director Michael Goettler resigned from the board effective June 30, 2026, upon his appointment as President and Chief Executive Officer of Knoa Pharma.Original SEC Filing: Bausch Health Companies Inc. [ BHC ] - 8-K - Jul. 01, 2026This is an AI-powered summary. It may contain inaccu…

Bausch Health's director Michael Goettler resigned from the board effective June 30, 2026, upon his appointment as President and Chief Executive Officer of Knoa Pharma.

IndividualMichael Goettler

RoleDirector (Board of Directors)

Type of ChangeResigned

Effective DateJune 30, 2026

ReasonAppointment as President and Chief Executive Officer of Knoa Pharma

Replacement InfoNot disclosed

Background DetailsNamed President and Chief Executive Officer of Knoa Pharma in connection with resignation

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.